1-2 of 2
Henry Krum
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effect of Insulin Glargine and n-3FA on Carotid Intima-Media Thickness in People With Dysglycemia at High Risk for Cardiovascular Events: The Glucose Reduction and Atherosclerosis Continuing Evaluation Study (ORIGIN-GRACE)

Eva M. Lonn, MD, Jackie Bosch, MSC, Rafael Diaz, MD, Patricio Lopez-Jaramillo, MD, Ambady Ramachandran, MD, Nicolae Hâncu, MD, PHD, Markolf Hanefeld, MD, Henry Krum, MBBS, PHD, Lars Ryden, MD, PHD, Sandra Smith, RDMS, Matthew J. McQueen, MD, PHD, Leanne Dyal, MSC, Salim Yusuf, MD, DPHIL, Hertzel C. Gerstein, MD, for the GRACE and ORIGIN Investigators
Journal: Diabetes Care
Diabetes Care 2013;36(9):2466–2474
https://doi.org/10.2337/dc12-2129
Published: 13 August 2013
View article titled, Effect of Insulin Glargine and n-3FA on Carotid Intima-Media Thickness in People With Dysglycemia at High Risk for Cardiovascular Events: <subtitle>The Glucose Reduction and Atherosclerosis Continuing Evaluation Study (ORIGIN-GRACE)</subtitle>
Open the PDF for Effect of Insulin Glargine and n-3FA on Carotid Intima-Media Thickness in People With Dysglycemia at High Risk for Cardiovascular Events: <subtitle>The Glucose Reduction and Atherosclerosis Continuing Evaluation Study (ORIGIN-GRACE)</subtitle> in another window
Includes: Supplementary data
Journal Articles

Utility of B-Type Natriuretic Peptide as a Screen for Left Ventricular Dysfunction in Patients With Diabetes : Response to Epshteyn et al.

Danny Liew, FRACP, Hans Schneider, FRACP, Joe D’Agostino, BSC, Jonathan Shaw, MD, Henry Krum, PHD
Journal: Diabetes Care
Diabetes Care 2004;27(3):848
https://doi.org/10.2337/diacare.27.3.848
Published: 01 March 2004
View article titled, Utility of B-Type Natriuretic Peptide as a Screen for Left Ventricular Dysfunction in Patients With Diabetes : <subtitle>Response to Epshteyn et al.</subtitle>
Open the PDF for Utility of B-Type Natriuretic Peptide as a Screen for Left Ventricular Dysfunction in Patients With Diabetes : <subtitle>Response to Epshteyn et al.</subtitle> in another window